Prevention of intraventricular hemorrhage by indomethacin in male preterm infants

Area of Science:

• Neonatalogy
• Pediatric Neurology
• Clinical Pharmacology

Background:

• Intraventricular hemorrhage (IVH) is a serious complication in preterm infants.
• Existing treatments for IVH have limitations.
• The role of sex in IVH development and treatment response is not fully understood.

Purpose of the Study:

• To evaluate the efficacy of indomethacin in preventing IVH in preterm infants.
• To investigate potential sex differences in indomethacin's effect on IVH.
• To assess long-term neurodevelopmental outcomes, specifically verbal scores, in relation to indomethacin treatment and sex.

Main Methods:

• A multicenter trial involving preterm infants.
• Administration of indomethacin for IVH prevention.
• Analysis of IVH incidence and severity stratified by infant sex.
• Longitudinal assessment of verbal scores at 3 to 8 years of age.

Main Results:

• Indomethacin demonstrated a reduction in the overall incidence of IVH.
• In male infants, indomethacin halved IVH incidence and eliminated parenchymal hemorrhage.
• Boys treated with indomethacin showed higher verbal scores at long-term follow-up.

Conclusions:

• Indomethacin is effective in reducing IVH in preterm infants.
• There are significant sex-based differences in response to indomethacin for IVH prevention.
• Indomethacin may offer neuroprotective benefits, particularly for verbal development in boys.